stockrow
Saturday 7 November 2026
Export GRI’s income statement to Excel — free account
GRI Bio, Inc.
- EPS
- +97.5%
- Free cash flow
- +54.3%
Quarter to June 2026, against a year earlier
1.84
0.29
+18.71%
Follow GRI
Alert me
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
|
+8 more TTM periods Free account |
(465.42%) | (238.17%) | (185.67%) | (142.02%) | |
| (256.91%) | (166.00%) | (141.84%) | (113.27%) | ||
ROIC |
0.00% | 0.00% | 0.00% | 0.00% | |
Return on Tangible Assets |
(678.44%) | (200.87%) | (104.01%) | (94.36%) | |
Free Cash Flow per Share |
(98.44) | (103.84) | (9.78) | (5.77) | |
Free Cash Flow |
(9.21) | (10.20) | (12.13) | (10.41) | |
Capital Expenditures |
— | (0.01) | — | — | |
| Other line items | |||||
Cash ROIC |
(152.35%) | (71.62%) | (56.20%) | (49.06%) | |
Accounts Payable Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Average Days of Payables |
0.00 | 0.00 | 0.00 | 0.00 | |
Tax Rate |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Operating CF/Net income |
0.70 | 0.85 | 1.11 | 1.08 | |
Depreciation/Fixed assets |
4.00 | 1.33 | 2.00 | 1.50 | |
Capex/Depreciation |
0.00 | (2.75) | 0.00 | 0.00 | |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF per Share |
(98.44) | (103.73) | (9.78) | (5.77) | |
Capex per Share |
0.00 | (0.11) | 0.00 | 0.00 | |
Capex to Sales |
— | 0.00 | — | — |
Columns are period end dates · fundamentals updated 26 Oct 2026